Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway
Open Access
- 28 February 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-12
Abstract
Accumulating studies demonstrate that dihydromyricetin (DMY), a compound extracted from Chinese traditional herb, Ampelopsis grossedentata, attenuates atherosclerotic process by improvement of endothelial dysfunction. However, the underlying mechanism remains poorly understood. Thus, the aim of this study is to investigate the potential mechanism behind the attenuating effects of DMY on tumor necrosis factor alpha- (TNF-α-) induced endothelial dysfunction. In response to TNF-α, microRNA-21 (miR-21) expression was significantly increased in human umbilical vein endothelial cells (HUVECs), in line with impaired endothelial dysfunction as evidenced by decreased tube formation and migration, endothelial nitric oxide synthase (eNOS) (ser1177) phosphorylation, dimethylarginine dimethylaminohydrolases 1 (DDAH1) expression and metabolic activity, and nitric oxide (NO) concentration as well as increased asymmetric dimethylarginine (ADMA) levels. In contrast, DMY or blockade of miR-21 expression ameliorated endothelial dysfunction in HUVECs treated with TNF-α through downregulation of miR-21 expression, whereas these effects were abolished by overexpression of miR-21. In addition, using a nonspecific NOS inhibitor, L-NAME, also abrogated the attenuating effects of DMY on endothelial dysfunction. Taken together, these data demonstrated that miR-21-mediated DDAH1/ADMA/NO signal pathway plays an important role in TNF-α-induced endothelial dysfunction, and DMY attenuated endothelial dysfunction induced by TNF-α in a miR-21-dependent manner.Keywords
Funding Information
- National Natural Science Foundation of China (81400331, 81703818, 81602846, 2015JJ3138, ZR2016HQ21)
- National Natural Science Foundation of China (81400331, 81703818, 81602846, 2015JJ3138, ZR2016HQ21)
- National Natural Science Foundation of China (81400331, 81703818, 81602846, 2015JJ3138, ZR2016HQ21)
- Natural Science Foundation of Hunan Province (81400331, 81703818, 81602846, 2015JJ3138, ZR2016HQ21)
- Natural Science Foundation of Shandong Province (81400331, 81703818, 81602846, 2015JJ3138, ZR2016HQ21)
This publication has 44 references indexed in Scilit:
- 4-HNE Increases Intracellular ADMA Levels in Cultured HUVECs: Evidence for miR-21-Dependent MechanismsPLOS ONE, 2013
- Effects of Chinese herbal medicine Yiqi Huaju Qingli Formula in metabolic syndrome patients with microalbuminuria: a randomized placebo-controlled trialJournal of Integrative Medicine, 2013
- The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndromeCellular & Molecular Immunology, 2011
- MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammationProceedings of the National Academy of Sciences, 2011
- Dimethylarginine Dimethylaminohydrolase 1 Modulates Endothelial Cell Growth Through Nitric Oxide and AktArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- A Novel Loss-of-Function DDAH1 Promoter Polymorphism Is Associated With Increased Susceptibility to Thrombosis Stroke and Coronary Heart DiseaseCirculation Research, 2010
- Role of the PRMT–DDAH–ADMA axis in the regulation of endothelial nitric oxide productionPharmacological Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Isoform-Specific Regulation by N G , N G -Dimethylarginine Dimethylaminohydrolase of Rat Serum Asymmetric Dimethylarginine and Vascular Endothelium-Derived Relaxing Factor/NOCirculation Research, 2007
- Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2Circulation Research, 2007